Hester Biosciences Limited has clarified with reference to the news on Hester tying up with Gujarat Biotechnology Research Centre, Department of Science & Technology, Government of Gujarat and with Omnibrx towards manufacturing Covid vaccine.
A triparty consortium has been formed with Government of Gujarat as the lead partner, to explore the prospects of manufacturing the Covid vaccine through technology from Bharat Biotech.
The discussions are currently on-going with Bharat Biotech towards reviewing the infrastructure at Hester, the technology adaption process and the regulatory compliances. Based on the outcome of the review, the next course of action will be determined.
Shares of HESTER BIOSCIENCES LTD. was last trading in BSE at Rs.2470.05 as compared to the previous close of Rs. 2214.75. The total number of shares traded during the day was 44353 in over 8731 trades.
The stock hit an intraday high of Rs. 2657 and intraday low of 2205. The net turnover during the day was Rs. 111293014.